Highlights
- Lotus Resources has launched an institutional placement targeting approximately AUD 76 million.
- Proceeds are earmarked to support uranium production ramp-up and working capital requirements.
- A separate share purchase plan seeks to raise up to AUD 5 million from eligible shareholders.
Lotus Resources Limited (ASX:LOT) has announced a non-underwritten equity placement aiming to raise approximately AUD 76 million (USD 53 million) before costs. The placement is priced at AUD 2.15 per share and involves the issue of around 35.4 million new fully paid ordinary shares to institutional and sophisticated investors. The capital raise is intended to provide additional working capital during the ramp-up phase at the Kayelekera uranium project as the company progresses toward steady-state production.
In addition to the placement, the company plans to undertake a non-underwritten share purchase plan (SPP) targeting up to AUD 5 million (USD 3 million). Eligible shareholders in Australia and New Zealand will be able to apply for up to AUD 30,000 worth of shares at the same offer price, subject to regulatory approvals.
Balance Sheet Position and Use of Funds
Following completion of the placement and SPP, Lotus expects pro-forma unaudited cash of approximately AUD 145 million. This figure includes cash on hand as of 31 December 2025, equipment finance drawn after the quarter end, and gross proceeds from the equity raising.
The funds are intended to support completion of the acid plant and grid connection projects, which are expected to influence operating cost structures. The cash balance is also designed to cover the typical uranium working capital cycle of approximately five to six months. The company has noted that inventory pre-payment facilities are under negotiation and could provide additional liquidity if required.
Operational Timeline and Production Outlook
Lotus is targeting monthly nameplate production of around 200 thousand pounds of uranium, equivalent to approximately 2.4 million pounds per annum, during the second quarter of calendar year 2026. Product qualification assessments are ongoing, with one western converter confirming that initial samples meet required specifications for key parameters. Final product acceptance is anticipated during February 2026.
The first shipment of uranium product is expected in Q2 CY2026, subject to qualification, testing, final preparation, and permitting. Initial cash receipts are targeted for Q3 CY2026.
Placement Structure and Timetable
The placement is being conducted under the company’s existing ASX Listing Rule 7.1 capacity and is not underwritten. New shares issued will rank equally with existing ordinary shares. Settlement is scheduled for 6 February 2026, with allotment expected on 11 February 2026. The SPP is expected to open on 12 February 2026, with shares to be issued in March, subject to final conditions.
Share Performance
Lotus Resources traded at AUD 2.88 on 4 February 2026.
With funding initiatives underway, Lotus Resources is moving through a capital-intensive phase as it advances Kayelekera toward steady-state uranium production, while maintaining liquidity to manage operational and working capital requirements during the transition period.
FAQs
Q1. How much capital is Lotus Resources seeking to raise through the placement?
The company is targeting approximately AUD 76 million before costs through a non-underwritten placement.
Q2. What is the purpose of the share purchase plan?
The SPP is intended to raise up to AUD 5 million and allows eligible shareholders to participate at the placement price.
Q3. When is Lotus expecting its first uranium shipment?
The first shipment is expected in Q2 CY2026, subject to product qualification and regulatory approvals.
Disclaimer:
This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.
Kalkine does not issue, sell or deal in any financial products.
This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.
To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.